SOPH
SOPHiA Genetics SA

238
Loading...
Loading...
News
all
press releases
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in...
PR Newswire·3h ago
News Placeholder
More News
News Placeholder
Strategic Partnerships Power Tempus AI's Healthcare Expansion
TEM deepens collaborations in oncology and neuroscience using its Lens and Next platforms to accelerate precision medicine.
Zacks·2mo ago
News Placeholder
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
Tempus AI's soaring Q2 revenues, margin gains and near-EBITDA breakeven position it as a fast-rising force in precision medicine.
Zacks·2mo ago
News Placeholder
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
TEM surged 34.5% in Q2 on AI-driven deals and product momentum, but valuation and profit concerns linger ahead of earnings.
Zacks·3mo ago
News Placeholder
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.
Zacks·3mo ago
News Placeholder
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?
Zacks·4mo ago
News Placeholder
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?
Zacks·5mo ago
News Placeholder
Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy Testing
Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy Testing Leading Healthcare Institutions Adopt MSK-ACCESS for Liquid Biopsy Testing PR Newswire BOSTON, MA and ROLLE, Switzerland...
PR Newswire·8mo ago
News Placeholder
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025 SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4...
PR Newswire·8mo ago
News Placeholder
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities PR Newswire BOSTON, MA and ROLLE, Switzerland, Jan. 28, 2025 The...
PR Newswire·9mo ago

Latest SOPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.